BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34661773)

  • 1. Hybridoma technology; advancements, clinical significance, and future aspects.
    Mitra S; Tomar PC
    J Genet Eng Biotechnol; 2021 Oct; 19(1):159. PubMed ID: 34661773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
    Parray HA; Shukla S; Samal S; Shrivastava T; Ahmed S; Sharma C; Kumar R
    Int Immunopharmacol; 2020 Aug; 85():106639. PubMed ID: 32473573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and Selection of Monoclonal Antibodies.
    Hanack K; Messerschmidt K; Listek M
    Adv Exp Med Biol; 2016; 917():11-22. PubMed ID: 27236550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybridoma-free generation of monoclonal antibodies.
    Pasqualini R; Arap W
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):257-9. PubMed ID: 14688405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a novel monoclonal antibody against inflammatory biomarker S100A8 using hybridoma technology.
    Kim JP; Yun H; Kim EJ; Kim YG; Lee CS; Ko BJ; Kim BG; Jeong HJ
    Biotechnol Lett; 2023 Jun; 45(5-6):589-600. PubMed ID: 36971774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Hybridoma Technology on the R&D of Idiotypic Antibodies.
    Kohler H
    Monoclon Antib Immunodiagn Immunother; 2021 Feb; 40(1):2-5. PubMed ID: 33535018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress in the rapid preparation of monoclonal antibodies of mouse hybridoma].
    Fang S; Liu C; Ma J; Yan S; Xu D; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2293-2306. PubMed ID: 34327896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line.
    Ghaderi F; Ahmadvand S; Ramezani A; Montazer M; Ghaderi A
    Biochem Biophys Res Commun; 2018 Oct; 505(1):181-186. PubMed ID: 30243716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
    Yang LJ; Wang WL
    World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid, simple, and effective strategy to produce monoclonal antibodies targeting protein structures using hybridoma technology.
    Sakaguchi A; Tanaka Y; Shoji E; Takeshima T; Sakamaki R; Matsuba T; Kurihara Y
    J Biol Eng; 2023 Mar; 17(1):24. PubMed ID: 36997993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
    Holzlöhner P; Hanack K
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
    Liu H
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
    Aydın C; Ataoğlu H
    Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization and fusion protocols for hybridoma production.
    Wood JN
    Methods Mol Biol; 1984; 1():261-70. PubMed ID: 20512695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology.
    Muhsin A; Rangel R; Vien L; Bover L
    Methods Mol Biol; 2022; 2435():73-93. PubMed ID: 34993940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique.
    Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F
    Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.